Zevra Therapeutics Presents Design of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia  ( IH )  at Beyond Sleepy 2023 - Zevra Therapeutics  ( NASDAQ:ZVRA )